多学科风湿科/皮肤科诊所中银屑病和银屑病关节炎的管理
Management of Psoriasis and Psoriatic Arthritis in a Multidisciplinary Rheumatology/Dermatology Clinic.
作者信息
Cunha Joanne Szczygiel, Qureshi Abrar A, Reginato Anthony M
机构信息
is an assistant professor of medicine and an attending physician in the Division of Rheumatology, is the chief of dermatology, and is the rheumatology program director as well as director of rheumatology research and musculoskeletal ultrasound, all at the Warren Alpert Medical School of Brown University. Dr. Cunha and Dr. Qureshi are attending physicians and Dr. Reginato is acting chief of rheumatology, all at the Providence VA Medical Center.
出版信息
Fed Pract. 2015 Dec;32(Suppl 12):14S-20S.
Abstract
Early diagnosis, use of newly developed targeted therapies, and a multispecialty approach are essential for the treatment of patients with psoriasis and psoriatic arthritis.
摘要
早期诊断、使用新开发的靶向疗法以及多专科方法对于银屑病和银屑病关节炎患者的治疗至关重要。
相似文献
1
Management of Psoriasis and Psoriatic Arthritis in a Multidisciplinary Rheumatology/Dermatology Clinic.
Fed Pract. 2015 Dec;32(Suppl 12):14S-20S.
2
Multidisciplinary dermatology-rheumatology management for patients with moderate-to-severe psoriasis and psoriatic arthritis: a systematic review.
Rheumatol Int. 2016 Feb;36(2):221-9. doi: 10.1007/s00296-015-3377-z. Epub 2015 Oct 5.
3
Early Recognition and Treatment Heralds Optimal Outcomes: the Benefits of Combined Rheumatology-Dermatology Clinics and Integrative Care of Psoriasis and Psoriatic Arthritis Patients.
Curr Rheumatol Rep. 2017 Nov 20;20(1):1. doi: 10.1007/s11926-017-0706-0.
4
Bridging the Gaps in the Care of Psoriasis and Psoriatic Arthritis: the Role of Combined Clinics.
Curr Rheumatol Rep. 2018 Oct 26;20(12):76. doi: 10.1007/s11926-018-0785-6.
5
A multidisciplinary approach in psoriatic disease: the different models of dermatology-rheumatology collaborations in Portugal.
Acta Reumatol Port. 2021 Oct-Dec;46(4):333-341.
6
Multidisciplinary psoriasis and psoriatic arthritis unit: report of 4 years' experience.
Actas Dermosifiliogr. 2014 May;105(4):371-7. doi: 10.1016/j.ad.2013.10.009. Epub 2013 Dec 18.
7
A report of 4 years of experience of a multidisciplinary unit of psoriasis and psoriatic arthritis.
Reumatol Clin. 2014 May-Jun;10(3):141-6. doi: 10.1016/j.reuma.2014.01.004. Epub 2014 Mar 20.
8
Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) Survey: Benefits and Challenges of Combined Rheumatology-dermatology Clinics.
J Rheumatol. 2017 May;44(5):693-694. doi: 10.3899/jrheum.170148.
9
Management of psoriasis and psoriatic arthritis in a combined dermatology and rheumatology clinic.
Arch Dermatol Res. 2012 Jan;304(1):7-13. doi: 10.1007/s00403-011-1172-6.
10
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic.
Clin Rheumatol. 2018 Oct;37(10):2741-2749. doi: 10.1007/s10067-018-4238-4. Epub 2018 Jul 29.
引用本文的文献
1
Practical and Relevant Guidelines for the Management of Psoriasis: An Inference-Based Methodology.
Dermatol Ther (Heidelb). 2022 Jan;12(1):253-265. doi: 10.1007/s13555-021-00642-5. Epub 2021 Dec 22.
2
Real-World Treatment Patterns and Healthcare Costs in Patients with Psoriatic Arthritis Treated with Ixekizumab: A Retrospective Study.
ACR Open Rheumatol. 2021 Dec;3(12):879-887. doi: 10.1002/acr2.11347. Epub 2021 Sep 22.
本文引用的文献
1
Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitors.
Ann Rheum Dis. 2016 Jan;75(1):311-5. doi: 10.1136/annrheumdis-2014-207201. Epub 2015 Sep 9.
2
Pharmacologic treatment of psoriatic arthritis and axial spondyloarthritis with traditional biologic and non-biologic DMARDs.
Best Pract Res Clin Rheumatol. 2014 Oct;28(5):793-806. doi: 10.1016/j.berh.2014.10.011. Epub 2014 Nov 22.
3
Comprehensive treatment of psoriatic arthritis: managing comorbidities and extraarticular manifestations.
J Rheumatol. 2014 Nov;41(11):2315-22. doi: 10.3899/jrheum.140882.
4
Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review.
J Rheumatol. 2014 Nov;41(11):2277-85. doi: 10.3899/jrheum.140876.
5
Systematic review of treatments for psoriatic arthritis: 2014 update for the GRAPPA.
J Rheumatol. 2014 Nov;41(11):2273-6. doi: 10.3899/jrheum.140875.
6
Tumour necrosis factor inhibitor monotherapy vs combination with MTX in the treatment of PsA: a systematic review of the literature.
Rheumatology (Oxford). 2015 May;54(5):915-26. doi: 10.1093/rheumatology/keu415. Epub 2014 Oct 27.
7
Current treatment of psoriatic arthritis: update based on a systematic literature review to establish French Society for Rheumatology (SFR) recommendations for managing spondyloarthritis.
Joint Bone Spine. 2015 Mar;82(2):80-5. doi: 10.1016/j.jbspin.2014.05.003. Epub 2014 Jul 2.
8
Development of criteria to distinguish inflammatory from noninflammatory arthritis, enthesitis, dactylitis, and spondylitis: a report from the GRAPPA 2013 Annual Meeting.
J Rheumatol. 2014 Jun;41(6):1249-51. doi: 10.3899/jrheum.140182.
9
Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor.
Ann Rheum Dis. 2014 Jun;73(6):1020-6. doi: 10.1136/annrheumdis-2013-205056. Epub 2014 Mar 4.
10
Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials.
Ann Rheum Dis. 2014 Jun;73(6):1000-6. doi: 10.1136/annrheumdis-2013-204741. Epub 2014 Feb 19.
Zotero 插件